Navigation Links
Data supporting three Antisoma programmes presented at AACR

had no effect on a fibroblast cell line representing normal, healthy tissue.

Separate experiments highlight the potential to combine AS1411 with other treatments. When AS1411 was used together with paclitaxel or cytarabine, synergistic killing was seen in a number of cancer cell lines.

New light is shed on the anti-cancer action of AS1411. The drug clearly induces apoptosis (programmed cell death). There are, however, differences from the killing pattern seen with many cytotoxic drugs, which generally achieve their maximum effect rapidly. By contrast, AS1411 acts more slowly, continuing to cause further cell death over a period of days.

AS1411 has completed phase I development, where it was shown to be very well-tolerated and produced two objective responses in late-stage renal cancer patients. Phase II trials in renal cancer and acute myeloid leukaemia (AML) are now planned and the drug may ultimately have potential against a variety of solid and blood cancers.

Preclinical support for AS1409 trial plans Antisoma recently announced that its forthcoming phase I trial of AS1409, an antibody-cytokine fusion protein, would enrol patients with renal cancer and melanoma. An AACR poster presents the data which supported this choice, showing strong expression of the drug's target in both of these cancer types.

Glyn Edwards, Antisoma's CEO, said: "Our AACR presentations illustrate the strength and breadth of our pipeline and highlight a number of ways to further expand the commercial opportunities for our key products, AS1404 and AS1411."

Copies of all the Antisoma posters are available at www.antisoma.com

Enquiries: Glyn Edwards, CEO Daniel Elger, Director of Communications +44 (0)20 8799 8200 Antisoma plc

Mark Court/Lisa Baderoon/Rebecca Skye Dietrich +44 (0)20 7466 5000 Buchanan Communications

Brian Korb
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Antisoma plc (UK) - Second lung cancer trial adds to positive data on AS1404
3. CYT003-QbG10 to treat allergy to be presented at the Congress of the European Academy of Allergology and Clinical Immunology (EAACI), June 9-13, 2007
4. Data to be presented at AAN Meeting -Study results of drug candidate for MS
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Data supporting three Antisoma programmes presented AACR
(Date:5/24/2013)... N.J. , May 24, 2013  BD (Becton, Dickinson ... medical technology company, announced today that it will present at ... on Thursday, May 30, 2013, at 10:40 a.m. (ET). ... accessed from the BD corporate website at www.bd.com/investors ... 2013.    About BD BD is ...
(Date:5/24/2013)... LOS ANGELES , May 24, 2013  An ... gathered on Saturday, May 18, in Santa ... findings on new lung-sparing therapies for MPM, a rare ... and commonly affects the pleura, the lining of the ... Heart, Lung and Blood Institute, the 3rd Annual International ...
(Date:5/24/2013)... May 24, 2013  Auxilium Pharmaceuticals, Inc. (Nasdaq: ... participate in the Deutsche Bank Health Care Conference to ... Hotel.  Mr. Adrian Adams , Chief ... overview of the Company and its product pipeline at ... (Logo: http://photos.prnewswire.com/prnh/20101202/MM10881LOGO ) The ...
Breaking Medicine Technology:International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma 2International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma 3Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 2Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 3Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 4
... PARSIPPANY, N.J., April 8, 2011 Pacira Pharmaceuticals, Inc. (NASDAQ: ... announced James Scibetta, chief financial officer, is scheduled to present ... on Friday, April 15, 2011, at 11:30 a.m. EDT being ... New York City. Mr. Scibetta is expected to present an ...
... Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR ) ... activities will be highlighted at the 63rd Annual Meeting of ... HI, at the Hawaii Convention Center from April 9 through ... Pseudobulbar Affect on Social Function and Quality of Relationships: Results ...
Cached Medicine Technology:Pacira Pharmaceuticals to Present at BioCentury Future Leaders in the Biotech Industry Conference 2Avanir Pharmaceuticals to Present Data at the American Academy of Neurology Annual Meeting 2Avanir Pharmaceuticals to Present Data at the American Academy of Neurology Annual Meeting 3Avanir Pharmaceuticals to Present Data at the American Academy of Neurology Annual Meeting 4
(Date:5/24/2013)... research suggests a link between sleep duration and ... additional hour someone with insomnia sleeps is associated ... of moderate or high risk of suicide, according ... "We were surprised by the strength of ... study author, Linden Oliver, clinical research coordinator for ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 CHI-California ... Appropriators and the California congressional delegation, joined by ... sequestered industry user fees paid to the U.S. ... ensure that future across-the-board cuts will not include ... the FY14 Agriculture, Rural Development and FDA Appropriations ...
(Date:5/24/2013)... commonly used to treat glaucoma may cause droopy eyelids ... according to a new study. The drugs, known ... eye pressure, have already been shown to cause blurred ... said, suggesting that the new findings could lead to ... conservative when prescribing these drugs, the researchers added, particularly ...
(Date:5/24/2013)... York (PRWEB) May 24, 2013 Let’s face ... It is not uncommon for the majority of people to ... it is due to a coffee addiction or simply genetics, ... whitening procedures are so popular. , Herald Square ... and very effective whitening system: Venus White Max. , ...
(Date:5/24/2013)... 24, 2013 Area homeowners dreaming about owning ... hot tubs to choose from at factory-direct pricing during the ... sales event takes place at Emerald Pool and Patio ... , Jacuzzi, the industry's leading hot tub brand, scheduled the ... country. The event will feature popular hot tub models at ...
Breaking Medicine News(10 mins):Health News:Sleep Duration Linked to Suicidal Thoughts in People With Insomnia 2Health News:California Biomedical Industry Leaders Urge Congress to Take Action on FDA User Fees for FY2014 2Health News:California Biomedical Industry Leaders Urge Congress to Take Action on FDA User Fees for FY2014 3Health News:Common Glaucoma Drug May Cause Droopy Eyelids, Study Finds 2Health News:Herald Square Dental Introduces New In-office Whitening System: Venus White Max 2Health News:Truckload of Jacuzzi® Hot Tubs Rolls into Bend, Oregon on May 24, 2013 for Sales Event 2
... Disguised as lymph nodes, cancer can evade detection, researchers ... research from Switzerland provides insight into how tumors remain ... nodes. , "The tumor tricks the body into thinking ... of the Laboratory of Lymphatic and Cancer Bioengineering, said ...
... Take ... , ... -- PRcheck is a totally unique formula used by Borough PR (BPR) to assess the ... clients with an accurate calculation of the amount and type of coverage that an effective ...
... ... Terumo Medical Corporation, a U.S.-based subsidiary of Terumo Corporation, today announced ... growing training and information needs of physicians and other medical professionals interested ... site. As transradial adoption expands in the U.S., two key limiting ...
... diagnosed with breast cancer believe the risk of the disease ... times higher than it actually is. As a result, they ... perception of increased risk, according to new research. However, ... Frenchay Hospital (Bristol, UK), will tell the seventh European Breast ...
... Grove Dental, a ... convenience and services for patients , ... Chicago, IL (PRWEB) March 25, 2010 -- Grove Dental Associates, a multi-specialty dental practice ... dentist , announces the recent launch of its new Web site, www.GroveDental.com . The ...
... , ... www.megastockpicks.com ) gives it,s top buy recommendation to Pozen, Inc (NasdaqGM: POZN) upon approval of ... ... reputable internet-based free subscriber newsletter, announced today that they are initiating full coverage on pending ...
Cached Medicine News:Health News:Guaranteed PR Results from Borough PR with the New ‘PRcheck' 2Health News:U.S. Physician Demand for Transradial Access Education on the Rise New Transradial Access Site from Terumo Medical Corporation Supports Educational Need 2Health News:U.S. Physician Demand for Transradial Access Education on the Rise New Transradial Access Site from Terumo Medical Corporation Supports Educational Need 3Health News:U.S. Physician Demand for Transradial Access Education on the Rise New Transradial Access Site from Terumo Medical Corporation Supports Educational Need 4Health News:Patients requesting prophylactic mastectomies overestimate their breast cancer risk 2Health News:Patients requesting prophylactic mastectomies overestimate their breast cancer risk 3Health News:Leading Downers Grove Dentist Team at Grove Dental Launches New Web Site 2Health News:Mega Stock Picks (megastockpicks.com) Initiates Coverage on FDA Approval for POZEN, Inc.(NasdaqGM: POZN) Drug Vimovo with Immediate Buy Recommendation 2Health News:Mega Stock Picks (megastockpicks.com) Initiates Coverage on FDA Approval for POZEN, Inc.(NasdaqGM: POZN) Drug Vimovo with Immediate Buy Recommendation 3
Blood sedimentation rate analysis...
The Sedimat 15 Automated sedrate system provides an accurate ESR result in only 15 minutes. Fast, in-office results (before patient leaves the office) can lead to improved patient therapy....
The CA-500 series quickly and accurately measures up to 5 coagulation parameters. It is the analyzer of choice for low to mid volume laboratories, or as a backup to larger coagulation analyzers....
... incomparable auto-Lancet™ is the lancing device that ... and adjustability since 1983. This re-usable lancing ... for testing. The auto-Lancet is constructed in ... lancing day after day, year after year. ...
Medicine Products: